OpenAlex
PricingAboutJobs
Log inGet started
Work

Sacituzumab Govitecan: First Approval

HTML PDF

Year: 2020
Type: review
Source: Drugs
DOI: 10.1007/s40265-020-01337-5
Author: Yahiya Y. Syed
Institution: Springer Nature (New Zealand)
Language: English

Topic: Breast Cancer Treatment Studies
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: sacituzumab govitecan, TROP2, antibody-drug conjugates, topoisomerase I inhibitor, SN-38, metastatic triple-negative breast cancer, accelerated approval, drug development milestones, urothelial carcinoma, brain metastases, glioblastoma, endometrial cancer, prostate cancer
SDG: Good health and well-being

Open Access status: bronze

Funder: U.S. Food and Drug Administration
OpenAlex ID: W3035644303
FWCI: 3.428
Cites: 24
Cited by: 320
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms